Cycuria GmbH

Cycuria is a preclinical oncology start-up based in Graz, Austria. It was founded by scientists from the Medical University of Graz, the Technical University of Munich and the University of Heidelberg. Our goal is to develop new therapeutics based on our mechanistic understanding of a human cytokine and our expertise in protein engineering. Our biologics selectively target leukemic cells and their precursors, have an extended half-life for a sustained effect and minimal impact on healthy cells and tissues. We develop therapies for hematological and potentially also solid tumors and offer patients hope where conventional therapies have failed.

Contact:

ZWT-II Accelerator, Stiftingtalstrasse 14
8010 Graz / Austria

http://cycuria.com/